CASSANDRA EDGE: Open Payments
NPI 1689327520 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,597 in 68 payments from 18 companies in 2025. Trend: 2023 $1,954 · 2024 $2,870 · 2025 $1,597
Food & beverage: $1,597
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 10 | $309 |
| Novartis Pharmaceuticals Corporation | 8 | $199 |
| ABBVIE INC. | 7 | $193 |
| UCB, Inc. | 5 | $124 |
| PFIZER INC. | 5 | $102 |
| Biogen, Inc. | 6 | $96 |
| Lundbeck LLC | 4 | $88 |
| Neurelis, Inc. | 4 | $85 |
| TG Therapeutics, Inc. | 3 | $69 |
| Eisai Inc. | 3 | $56 |
Products named: INGREZZA, KESIMPTA, QULIPTA, TYSABRI, VALTOCO, NURTEC ODT, BOTOX, VYEPTI.
Industry payments across GA — which companies pay providers there.
